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Finding ways to control cancer at the primary site means the difference between life and death. 
Localized tumors can be eliminated by surgery and radiation therapy, and as a general rule do 
not represent a life-threatening problem. However, when cancer spreads to other tissues it 
becomes an incurable condition where treatments can only delay the progression of the 
disease and prolong survival.  
Carbon nanotubes (CNTs) represent a highly versatile heterogeneous family of nanomaterials 
that display interesting physico-chemical properties.[1] These nanomaterials are well-known to 
interact with the biological matter, penetrating inside tissues and cells,[2,3] leading to a 
plethora of side effects in living organisms.[4-7] In vitro, CNTs can be actively captured by 
most cells.[2-3] Once inside the cells, CNTs intermingle with many subcellular structures also 
at nano-scale, mostly filaments such as DNA,[8] actin[9,10] or microtubules.[5,11] In particular, 
multiwalled carbon nanotubes (MWCNTs) have been shown to contact cell surface 
receptors,[2] translocate across cell membranes via the endocytic pathway in both, phagocytic 
and non-phagocytic cells,[2,3] and interfere with the microtubule function triggering anti-
proliferative and pro-apoptotic effects.[5,10,11]  
MWCNTs display interesting biomimetic properties with microtubules.[11-13] These 
cytoskeletal elements are intracellular protein nanotubes that result from the self-association 
of tubulin into 4 nm polymers, known as protofilaments.[14] Tubulin protofilaments are 
organized into a circle assembling a 25 nm diameter tube, the microtubule (Figure S1). Thus, 
MWCNTs and microtubules are both 1D hollow nanofilaments with a similar length-to-
diameter ratio, resiliency, self-assembly properties and a comparable surface reactivity[12] that 
favors their association into bio-synthetic polymers both, in vitro[13] and in vivo.[11] There is 
however, a big difference between these two nanofilaments that has chief biotechnological 
implications. While CNTs are very stable filaments, microtubules are highly dynamic 
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the time scale of seconds both, in vitro and in vivo.[16,17] During mitosis, the microtubule 
dynamic behavior increases 20- to 100-fold to assemble the so-called “mitotic spindle”, a 
microtubule-based structure responsible for the balanced segregation of the chromosomes 
between the daughter cells.[17] Some of the most widely used anti-neoplastic drugs such as 
paclitaxel (taxol®) and their derivatives are microtubule-binding chemicals that behave as 
spindle poisons, inhibiting cell proliferation, leading to mitotic arrest and cell death.[16-19] 
MWCNTs interact tubulin intracellularly assembling biosynthetic filaments.[11] These hybrid 
microtubules display a significantly enhanced stability compared to the standard tubulin 
polymers that favors non-centrosomal cytoplasmic microtubule nucleation. As the word 
“centro-some” means, this structure is a key organizer of the microtubule cytoskeleton in the 
cell, participating in all cellular activities including cell division and migration. CNT-
triggered centrosomal abnormalities are well documented in the literature. These include 
aberrant mitotic spindle assemblies, chromosomal malsegregation, abnormal interphase 
microtubule arrays and cytotoxicity in general.[5,11,20] Since centrosomal positioning is a key 
structure in migrating cells, confering membrane and cytoskeletal directionality, here we 
determine if MWCNTs have the intrinsic ability to hinder cancer cell spreading and discuss 
the molecular mechanics behind this effect. 
For the study we first determined the position and trajectory of the centrosome in migrating 
HeLa cells treated with MWCNTs. As a rule of thumb, migrating cells display a polarized 
morphology[21] determined by the so-called, nuclear-centrosomal axis (Figure 1A). This axis, 
first identified by Van Beneden in the 1880s,[22] contributes to the asymmetric organization of 
cell structure during migration, and corresponds to the final direction of the displacement.[23] 
Microtubules, connected to the migrating front of the cell, pull forward the centrosome 
dragging the nucleus forward, thus redistributing the traction forces generated at the cell's 
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cell body translation. Accordingly, in cells migrating on 2D substrates, the centrosome is 
typically positioned between the nucleus and the leading edge, along this axis. To determine 
the orientation of nuclear-centrosomal axis we performed time-lapse video microscopy on live 
HeLa cells displaying fluorescently labelled centrosomes and nuclei (Experimental section). 
This allowed comparing this axis with the direction of the cell trajectory in migrating 
MWCNT-treated cells and untreated controls. As summarized in Figure 1B, in frozen live-
cell images obtained from Supporting Video 1-3, the centrosomes in MWCNT-treated cells 
displayed a random peri-nuclear location and were aberrantly positioned with respect to the 
nuclear trajectory. As a result, in MWCNT-treated cells the direction of the cell migration 
(white arrows) and the nuclear-centrosomal axes (yellow arrows) were not parallel. 
Conversely, in untreated-control HeLa cells centrosomes were located along the nuclear-
centrosomal axis, between the nucleus and the leading edge of the cells, just as described by 
Van Beneden.  
To investigate the consequences of these findings, we calculated the average migration speed 
of control and MWCNT-treated cells using cell tracking analysis (Experimental section). For 
the study we investigated various cancer cell lines including (i) HeLa cells, (ii) MCF7 cells, a 
human breast cancer cell line; (iii) SH-SY5Y cells, a neuroblastoma cell line originally 
established from a metastatic tumor; (iv) and U87MG cells, a grade IV human glioma cell line. 
Cells were incubated with 25 µg/ml MWCNTs for 70 h and were time-lapse video recorded 
for 5 h. This MWCNT concentration produced no obvious signs of toxicity but revealed a 
reduction of more than 40 % in the average speed of HeLa cells treated with MWCNTs. A 
statistically significant cell speed reduction was also shown for the other two fast-migrating 
cancer cell lines, SH-SY5Y and U87MG when exposed to MWCNTs (Table 1, Figure1C, D). 
A possible interference with MWCNTs settled on the growing matrix was also considered. 
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the growing matrix is never observed. Besides, recent studies have shown that CNTs facilitate 
cell migration.[24] 
To further demonstrate our hypothesis we decided to replicate this experiment on real tumor 
cells isolated from surgical specimens. Characteristically, tumor-explant derived cancer cells 
are much more heterogeneous than most cancer cell line models. We chose glioblastoma 
multiforme cells (GBM) for the study because these cells typically infiltrate the surrounding 
brain tissue leading to tumor recurrence after surgery. Glioblastomas are the most common 
and aggressive primary brain tumor in adults, and have an unfavorable prognosis with a 
median survival time of less than fifteen months, mostly due to recurrence. For the study we 
isolated GBM cells from surgical specimens that were fully characterized[25] before exposure 
to 25 µg/ml MWCNTs for 70 h. This experiment served to confirm that MWCNTs also 
triggered a significant anti-migratory effect (18 % speed reduction) in real tumor-derived cells 
(Figure 2A, Table 1).  
The presence of intracellular MWCNTs in GBM cells was confirmed using confocal Raman 
spectroscopy focusing the laser within the cell´s cytoplasm. We observed differences in the 
peak positions in the spectrum of intracellular MWCNTs, slightly shifted to higher 
wavenumbers (Figure 2B, inset), together with a decrease in Raman intensities of the D, G 
and G´ modes (Figure 2B, Supplementary Table 1). As it has been previously shown, CNTs 
exhibit variations in the relative Raman intensities and/or positions for various Raman modes 
depending on different physical[26] or chemical[27,28] environments and according their 
agglomeration state. In this study, functionalized intracellular MWCNTs display a well 
pronounced G mode indicative of a significant dispersion. The overall data also indicated that 
the coating of MWCNTs did not significantly affect the G mode profile, as previously 
reported for non-covalently-modified SWCNTs dispersed in aqueous solutions containing 


































































     
6 
 
MWCNTs was also determined on a single confocal Z plane obtained across the GBM cell 
cytoplasm using confocal Raman imaging, following the G band at 1586 cm-1 (Figure 2C, D). 
This technique revealed how intracellular MWCNTs were localized in small spots throughout 
the cytoplasm, a distribution coinciding with that previously described in MWCNT-treated 
cell lines.[11] These experiments demonstrate how MWCNTs can also translocate inside 
surgical specimen-derived cancer cells, and how these nanomaterials can also hinder GBM 
cell spreading. 
Finally, we also explored if the observed anti-migratory effect was dose-dependent. For the 
study we treated all the neural-derived cell lines and the primary GBM cell cultures with 0, 25, 
50 and 75 μg/ml of MWCNTs in the growing medium for 70 h. Again, this analysis 
confirmed a statistically significant speed reduction, of up to 62 %, with dosages of 50 μg/ml 
(Supplementary Table 2). Larger dosages (75 μg/ml) triggered a massive cytotoxic effect, 
suggesting excess MWCNTs probably interfere with some other critical cellular processes 
leading to cell death. 
The interaction of nanomaterials with proteins or lipids, the actual biological building blocks, 
is still poorly understood as reviewed by Tay and colleagues.[35] These studies demonstrate 
that MWCNTs could play a pivotal role in cancer treatment in combination to standard 
therapies interfering with cancer cell migration. Other nanomaterials such as TiO2, SiO2, and 
hydroxyapatite nanoparticles have also been recently shown to interfere with cell migration 
damaging the microtubule network.[36] Our work demonstrates that MWCNTs could play a 
pivotal role in cancer treatment in combination to standard therapies interfering with cancer 
cell migration. We have previously documented the molecular interaction of MWCNTs with 
tubulin intracellularly,[11] and how the biomimetic properties of MWCNTs  obstruct 
microtubule function during mitosis behaving as spindle poisons, same as traditional 
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microtubule is not site-specific. Instead MWCNTs appear to interact along the protofilament 
surface,[37] and this fact has two major advantages. First, MWCNTs do not require a specific 
binding site in the tubulin molecule subject of mutations. And second, the MWCNTs 
interaction with microtubules permits other microtubule-binding drugs to interact with their 
structural pocket in the tubulin molecule. Here we show how, in addition to the anti-
proliferative effect of MWCNTs, these nanomaterials also display important anti-migratory 
effects in cancer cells. This new intrinsic feature of MWCNTs could significantly boost the 
mechanism of action of traditional microtubule-binding cytotoxic chemotherapies[16-18] and 
thus might serve to bypass some of the drug-resistance mechanisms in cancer cells.[38] Being 
metastasis the primary cause of death for most cancers, we believe these new property of 
MWCNTs position these nanomaterials as a new ground-breaking type of future synthetic 
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Experimental Section  
MWCNTs synthesis and characterization 
CNTs of 3 to 12 walls, with outer diameter ranging from 5 to 15 nm were synthesized 
following the catalytic chemical vapor deposition method using Co and Mo particles as 
catalyst.[39] An aqueous HCl treatment procedure was applied to clean and separate the 
MWCNTs from contaminants. The as-prepared MWCNTs were characterized by various 
techniques including Raman spectroscopy, transmission electron microscopy (TEM) and 
thermo-gravimetric analyses (TGA) (Supporting Figure 2). MWCNTs produce a 
characteristic Raman spectrum distinguishable of SWCNTs spectrum revealing typical 
MWCNT resonances[40] such as the dispersive disorder induced D band at 1330 cm-1, the 
tangential G band at 1586 cm-1 and the D’ band at 1614 cm-1. TEM was performed in a JEOL 
JEM 2100 microscope operating at 120 kV. Samples were prepared using ethanol as 
dispersant and omitting the sample centrifugation steps. A drop of this suspension was 
adsorbed onto a Lacey copper grid. The TGA was performed with a Perkin Elmer Pyris 1 
system. Measurements were conducted by heating 9-12 mg of MWCNTs in dry air from 35° 
C up to 1000° C at a rate of 2° C min-1. TGA results showed a typical characteristic CNT 
curve where the oxidations of hexagonal carbon ring appeared at 550° C. Qualitative 
information on the purity of CNT could be obtained from the TGA based on the extent of 
non-oxidizable residues at high temperature. In our measurements, catalytic metal impurities 
were not observed between 600 and 1000° C. All these techniques confirmed the absence of 
undesired impurities in these MWCNTs samples. 
 
MWCNTs dispersion and functionalization 
CNTs were de-bundled and dispersed by repeated cycles of vortex mixing followed by mild 
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centrifugation in cell culture medium (DMEM, Dulbecco's Modified Eagle Medium from 
SIGMA-ALDRICH) containing serum and antibiotics as previously described.[10-13] The 
stability of the stock suspension was checked by centrifugation at 14.000 g after each 
sonication cycle. Visible absorption was used to determine MWCNT concentration in the 
400-600 nm range. Further details of the stability and dispersion of MWCNTs in the cell 
culture medium can be found in previous work.[10,11] A total of 3-5 cycles were sufficient to 
obtain a well-dispersed concentrated suspension of MWCNTs which was re-diluted in culture 
medium to the concentrations indicated in the text. 
 
Confocal Raman Spectroscopy Imaging 
A confocal Raman microscope (Alpha300, WITec) equipped with a piezo scanner and a linear 
polarized frequency doubled Nd:YAG laser (532 nm excitation wavelength) focused through 
an air objective (Nikon, 100X, NA= 0.9) was used. To avoid damage and heating, the laser 
power was controlled below 2 mW. The spatial resolution is diffraction limited. In the set-up 
used, features at a distance of r = 0.61 x 532/0.9= 0.36 μm can be distinguished and 
completely resolved at a distance of 0.72 μm. Mapping was done for the stack scan with a 
step size of 0.36 μm in X/Y and a constant Z (depth) in a square of 23 μm x 25 μm on X/Y. 
To get a better signal-to-noise ratio, every spectrum was acquired with an integration time of 
0.3 s, meaning 75 x 75= 5625 spectra for one image. Images from this multi-spectra file were 
computed by integrating the appropriate Raman peaks using the ScanCtrlSpectroscopyPlus 
software (WITec, Germany). The images were constructed mapping the signals of G mode 
(1500-1700 cm-1) and the C-H stretching in the 2800-3000 cm-1 region.[41] 
Cell culture, cell tracking and imaging techniques 
The human cancer cell line models used (HeLa, MCF7, SH-SY5Y and U87MG) have been 
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previously characterized by our group.[25] Cells were grown in DMEM media containing 10 % 
FCS at 37ºC, 5 % CO2 and were exposed to 25 µg/ml MWCNTs concentration in the culture 
medium for 70 h (unless otherwise indicated). Controls and MWCNT-treated cells were 
grown on the same culture plate and were imaged simultaneously. Centrosomal trajectories 
were labelled by gene-transfer with a vector expressing GFP:EB1 in HeLa cells 24 h before 
exposure to MWCNTs in the medium. This vector was kindly provided by Dr. Akhmanova 
(Utrecht University, The Netherlands). Nuclear DNA was labelled with Hoechst dye (Bis-
benzimide) (Sigma-Aldrich). Cell tracking analysis was performed on time-lapse video 
microscopy movies obtained @ 15 min/frame during 5 h on a Nikon Eclipse Ti live-cell 
station, using a 10X Nikon N.A. 0.45. Quantification analysis was performed with the NIS-
Elements software. The average cell migration speed was obtained for a minimum of hundred 
cells in at least 3 sets of experiments for each condition. Actual numbers of analyzed cells are 
designated in Table 1 as degrees of freedom (DF). Unpaired two-tailed Student's t test was 
used for the statistical evaluation of differences between control and treated cells. Probability 
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DF b) t/p c) 
% Statistical 
Significance 
HeLa 12.7 ± 0.6 7.4 ± 0.4 41 % 245 7.2/ <10-10 >99.99 
MCF7 1.6 ± 0.1 1.5 ± 0.1 6 % 130 0.4/ 0.64 NS 
SH-SY5Y 8.7 ± 0.7 6.8 ± 0.4 22 % 114 2.3/ 0.02 95-98 
U87MG 8.5 ± 0.2 6.1 ± 0.2 28 % 249 7.1/ <10-10 >99.99 
GBM 9.2 ± 0.2 7.5 ± 0.1 18.5 % 408 6.5/ <10-9 >99.99 






















































































Figure 1. MWCNTs produce centrosomal miss-positioning and disrupt the nuclear-
centrosomal axis hindering cell migration.  
A) Diagram of the disposition of the nucleus (N), centrosome (C, green) and microtubule 
array (red filaments) in control and MWCNT-treated (MWCNTs in black) migrating cells. 
Microtubule traction forces are also represented (small white and black arrows). The cell 
polarity and migratory direction (white arrow) relative to the nuclear-centrosomal axis 
(yellow arrow) is indicated.  
B) Frozen live-cell images obtained from time-lapse videos 1-3 (Supporting Video 1-3) of 
migrating HeLa cells displaying labelled nuclei (blue) and centrosomes (green). The 
centrosomal trajectories (red arrows), average cell trajectories (white arrows) and nuclear-
centrosomal axes (yellow arrows) are shown for MWCNT-treated cells and untreated controls. 
C-D) Representative glioblastoma (U87MG) and neuroblastoma (SH-SY5Y) 5 h cell tracking 
trajectories, respectively. Cultures grown in the absence (control) or presence of MWCNTs 
were recorded during 70 h. Individual cell trajectories indicated by colored lines, are shorter 








































































Figure 2. MWCNTs translocate into the cytoplasm of surgical specimen-derived cancer cells 
and interfere with cell spreading.  
A) Phase contrast microscopy images of the primary cultures of GBM cells obtained from 
surgical specimens. Both control and MWCNT-treated cells display a long bipolar 
morphology and no observable toxicity signs. Colored lines indicate 5 h cell trajectories. 
B) Comparison between the Raman spectra of pristine MWCNTs (black) and intracellular 
MWCNTs (red trace). These Raman spectra were obtained with a 532 nm line of a linear 
polarized frequency doubled Nd:YAG laser. The inset shows a detail of the typical 
fingerprints expected for MWCNTs spectral region corresponding to the D and G bands in 
order to point out the blue-shift of the Raman peak frequencies associated with the 
functionalization of the intracellular MWCNTs. Though only minor differences in the peak 


































































     
19 
 
to higher wavenumbers and a decrease in Raman intensities of D and, G and G´ modes are 
observed (Supporting Table 1).  
C) Phase contrast image a GBM cell captured through 100X objective of the confocal Raman 
microscope. (center) Single confocal Z plane Raman image of the same cell obtained 
integrating the intensities in the 2800-3000 cm-1 region (C-H stretching), integration time of 
0.3 s x 10 accumulations and a point spacing of 0.36 μm. (right) Confocal Raman image 
obtained at the same confocal Z plane to determine the localization of intracellular MWCNTs 
integrating the Raman intensities of the G-band (1500-1700 cm-1 region). As shown in the 
color scale (indicating maximum/minimum CCD counts), bright yellow hues indicate the 
highest signals and grey hues low integrated G band intensities.  
D) Confocal Raman spectra of the cytoplasm of a MWCNT-treated GBM cell (inset, blue 
cross) and extracellular functionalized MWCNTs (inset, red cross). Integration time of 0.5 s x 
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The table of contents: 
 
Inhibiting cancer cell migration and infiltration to other tissues makes the difference 
between life and death. MWCNTs display intrinsic biomimetic properties with microtubules, 
severely interfering with the function of these filaments during cell proliferation, triggering 
cell death. Here we demonstrate how MWCNTs disrupt the centrosomal microtubule 
cytoskeletal organization in cancer cells triggering potent anti-migratory effects. Our data 
validate these nanomaterials as future adjuvant therapies to boost the effect of traditional 
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